B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Nature Medicine

Volumn 5, Issue 12, 1999, Pages 1365-1369

  Dong, Haidong ^a   Zhu, Gefeng ^a   Tamada, Koji ^a   Chen, Lieping ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2;

ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD80; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-10; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES; TRANSFECTION;

EID: 0032736029     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/70932     Document Type: Article

References (23)

1. Chambers, C.A. & Allison, J.P. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 369-404 (1997).
2. Lenschow, D.J., Walunas, T.L. & Bluestone, J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258 (1996).
3. Chen, L., Linsley, P.S. & Hellstrom, K.E. Costimulation of T cells for tumor immunity. Immunol. Today 14, 483-486 (1993).
4. Boise, L.H., Noel, P.J. & Thompson, C.B. CD28 and apoptosis. Curr Opin. Immunol. 7, 620-625 (1995).
5. Krummel, M.F. & Allison, J.P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med 183, 2533-2540 (1996).
6. Walunas, T.L., Bakker, C.Y. & Bluestone, J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541-2550 (1996).
7. Hutloff, A. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263-266 (1999).
8. Moore, K.W. et al. Interleukin-10. Annu. Rev. Immunol. 11, 165-190 (1993).
9. Freeman, G.J. et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262, 909-911 (1993).
10. Azuma, M. et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79 (1993).
11. Peach, R.J. et al. Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptor CTLA-4 and CD28. J. Biol. Chem. 270, 21181-21187 (1995).
12. Fargeas, C.A. et al. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA-4. J. Exp. Med. 182, 667-675 (1995).
13. Bajorath, J., Peach, R. J. & Linsley, P. S. Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86). Protein Sci. 3, 2148-2150 (1994).
14. Linsley, P.S. et al. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793-801 (1994).
15. Inaba, K. et al. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180, 1849-1860 (1994).
16. Freeman, C. J. et al. B7-1 and B7-2 do not deliver identical costimulatory signals since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532 (1995).
17. Nakajima, A. et al. Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int. Immunol. 9, 637-644 (1997).
18. Schwartz, R. H. T cell clonal anergy. Curr. Opin. Immunol. 9, 351-357 (1997).
19. Georgescu, L, Vakkalanka, R.K, Elkon, K.B. & Crow, M.K. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest. 100, 2622-2633 (1997).
20. Goerdt, S. & Orfanos, C. E. Other functions, other genes: Alternative activation of antigen-presenting cells. Immunity 10, 137-142 (1999).
21. Li, Y, McGowan, P., Hellstrom, K.E. & Chen, L. Costimulation of tumor-reactive CD44+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J. Immunol. 153, 421-428 (1994).
22. Chen, L. et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093-1102 (1992).
23. Li, Y., Hellstrom, K.E., Newby, S.A. & Chen, L. Costimulation by CD48 and 87-1 induces immunity against poorly immunogenic tumors. J. Exp. Med. 183, 639-644 (1996).